The stock of Fulgent Genetics (NASDAQ: FLGT), a genetic testing company, is up more than 300% this year. Learn more. Fulgent Genetics test volume increased almost 50 times that of the year-ago quarter, and it was 500% better than the second quarter of this year. Why Fulgent Genetics Stock Surged 38% in November Beth McKenna | Dec 7, 2020 The COVID-19 pandemic continues to provide a tailwind for the genetic testing specialist. FULGENT GENETICS, INC. : News, information and stories for FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq Shares of genetic testing specialist Fulgent Genetics (NASDAQ:FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. Fulgent Genetics had a net margin of 35.31% and a return on equity of 43.81%. Get the latest news and breaking stories for Fulgent Genetics (FLGT) stock. 10 stocks we like better than Fulgent Genetics, Inc. View our earnings forecast for Fulgent Genetics. The company can be reached via phone at 626-350-0537 or via email at [email protected]. Fulgent Genetics Inc's average analyst price target is greater than 93.16% of stocks in the small market cap category. View insider buying and selling activity for Fulgent Genetics or view top insider-selling stocks. This Small-Cap … Shares of genetic testing specialist Fulgent Genetics (NASDAQ: FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. Fulgent Genetics employs 473 workers across the globe. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. ), Fulgent Genetics has received 255 “underperform” votes. FLGT has a greater number of analysts covering the stock than 34.62% of Healthcare stocks. FLGT, Fulgent Genetics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Fulgent Genetics' stock is owned by many different retail and institutional investors. For … Since then, FLGT shares have increased by 395.7% and is now trading at $49.87. (Add your “underperform” vote.). © 2020 Verizon Media. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Fulgent Genetics does not currently pay a dividend. Fundamental company data provided by Morningstar and Zacks Investment Research. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The official website for Fulgent Genetics is Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19: May 18, 2020 Fulgent Genetics Receives Emergency Use Authorization from the FDA for its RT-PCR Test for Detection of SARS-CoV-2, the Virus that Causes COVID-19: May 4, 2020 Fulgent Genetics Reports First Quarter 2020 Financial Results View insider buying and selling activity for Fulgent Genetics or or view top insider-buying stocks. Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.83. Please log in to your account or sign up in order to add this asset to your watchlist. MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. Some companies that are related to Fulgent Genetics include CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX), Centogene (CNTG), DermTech (DMTK), Progenity (PROG), Exagen (XGN), Enzo Biochem (ENZ), Celcuity (CELC) and Biocept (BIOC). If you invested a modest $1,000 into shares of Fulgent Genetics (NASDAQ:FLGT) back in January, that investment would have turned into $3,750 as of Dec. 8. (5.60%), State Street Corp (1.20%), Old West Investment Management LLC (0.77%), Morgan Stanley (0.48%) and Principal Financial Group Inc. (0.47%). Fulgent could customize tests for customers, for about 5,700 different genetic conditions. All rights reserved. Fulgent Genetics, Inc. (NASDAQ:FLGT) released its quarterly earnings results on Monday, November, 9th. View the latest Fulgent Genetics Inc. (FLGT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Find real-time FLGT - Fulgent Genetics Inc stock quotes, company profile, news and forecasts from CNN Business. Fulgent Genetics Inc's upside potential (average analyst target price relative to current price) is higher than 74.71% of all US stocks. Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. All rights reserved. FULGENT GENETICS, INC. (NASDAQ:FLGT) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Pre-Market earnings guidance on Monday, November, 23rd. (Add your “outperform” vote. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Year-to-date, Fulgent Genetics Inc. (NASDAQ:FLGT) stock gained 273.1% and on August 20th it had a closing price of $50.51. Learn more. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings. View all competitors. Check out these five high earnings yield stocks that can make you rich, irrespective of the Santa rally or a year-end pullback. Fulgent Genetics has a market capitalization of $1.09 billion and generates $32.53 million in revenue each year. After all, the newsletter they have run for over a … Why Fulgent Genetics Stock Is Soaring 11.2% Today The Motley Fool 11/13/2020. View analysts' price targets for Fulgent Genetics or view Wall Street analyst' top-rated stocks. Since then, FLGT stock has increased by 347.6% and is now trading at $45.03. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. To see all exchange delays and terms of use please see disclaimer. The company earns $-410,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The … This suggests a possible upside of 23.9% from the stock's current price. Export data to Excel for your own analysis. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. (FLGT) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. That is … MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Get short term trading ideas from the MarketBeat Idea Engine. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. You may vote once every thirty days. 45.00% of the stock of Fulgent Genetics is held by insiders. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Get the latest Fulgent Genetics, Inc. (FLGT) stock news and headlines to help you in your trading and investing decisions. On average, they anticipate Fulgent Genetics' stock price to reach $55.80 in the next year. A high percentage of insider ownership can be a sign of company health. Fulgent Genetics has received 228 “outperform” votes. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). FLGT stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Raymond James Trust N.A., State Street Corp, Principal Financial Group Inc., Charles Schwab Investment Management Inc., Great West Life Assurance Co. Can, Great West Life Assurance Co. Can, and Wells Fargo & Company MN. Only 31.05% of the stock of Fulgent Genetics is held by institutions. Their forecasts range from $20.00 to $100.00. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Fulgent Genetics against related stocks people have also bought. Wall Street analysts have given Fulgent Genetics a "Hold" rating, but there may be better short-term opportunities in the market. Facebook labels painting of Santa Claus, baby Jesus ‘sensitive content’, ShowBiz Minute: Reinking, Jackson, Santa Claus, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. The company provided EPS guidance of for the period. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Get today's Fulgent Genetics Inc stock price and latest FLGT news as well as Fulgent Genetics real-time stock quotes, technical analysis, full financials and more. Company insiders that own Fulgent Genetics stock include Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul Kim. Want to see which stocks are moving? Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. View institutional ownership trends for Fulgent Genetics. Shares of FLGT can be purchased through any online brokerage account. Fulgent Genetics has received 52.80% “underperform” votes from our community. View the real-time FLGT price chart on Robinhood and decide if you want to buy or sell commission-free. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Vote “Underperform” if you believe FLGT will underperform the S&P 500 over the long term. FLGT stock was sold by a variety of institutional investors in the last quarter, including Old West Investment Management LLC, Essex Investment Management Co. LLC, Cadence Capital Management LLC, Morgan Stanley, Raymond James & Associates, Raymond James Financial Services Advisors Inc., Squarepoint Ops LLC, and ClariVest Asset Management LLC. Do Not Sell My Information. The company primarily serves hospitals and medical institutions. According to analysts' consensus price target of $55.80, Fulgent Genetics has a forecasted upside of 23.8% from its current price of $45.09. Get the latest Fulgent Genetics Inc (FLGT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The company issued 4,600,000 shares at $12.00-$14.00 per share. View our full suite of financial calendars and market data tables, all for free. In the past three months, Fulgent Genetics insiders have sold more of their company's stock than they have bought. Fulgent Genetics does not have a long track record of dividend growth. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Top institutional investors include BlackRock Inc. (7.18%), Raymond James Trust N.A. Fulgent Genetics is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021. Earnings for Fulgent Genetics are expected to grow by 32.35% in the coming year, from $4.08 to $5.40 per share. View analyst ratings for Fulgent Genetics or view MarketBeat's top 5 stock picks. Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Inseego (INSG), NeoGenomics (NEO), Invitae (NVTA), Square (SQ), (JD), Marvell Technology Group (MRVL), Teladoc Health (TDOC) and Editas Medicine (EDIT). Fulgent Genetics updated its FY 2020 Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT.". LANES, Fulgent Genetics and LA ... News 11/10/2020. TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that it has updated its revenue guidance for the full year 2020 due to accelerating demand for its COVID-19 testing solutions. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter. View which stocks are hot on social media with MarketBeat's trending stocks report. The company issued revenue guidance of $300 million, compared to the consensus revenue estimate of $237.38 million. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Find the latest news headlines from Fulgent Genetics, Inc. Common Stock (FLGT) at Fulgent Genetics has a P/B Ratio of 10.20. Learn everything you need to know about successful options trading with this three-part video course. Credit Suisse and Piper Jaffray acted as the underwriters for the IPO and Raymond James and BTIG were co-managers. Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. Should You Buy the Peloton (NASDAQ: PTON) Rally? Yahoo | December 10, 2020 Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Fulgent Genetics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.51. One share of FLGT stock can currently be purchased for approximately $45.03. Get daily stock ideas top-performing Wall Street analysts. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 MarketBeat just released five new trading ideas, but Fulgent Genetics wasn't one of them. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California. View Fulgent Genetics' earnings history. Receive a free world-class investing education from MarketBeat. Looking for new stock ideas? Company insiders that have sold Fulgent Genetics company stock in the last year include Hanlin Gao, Jian Xie, John C Bolger, and Paul Kim. View which stocks have been most impacted by COVID-19. A high-level overview of Fulgent Genetics, Inc. (FLGT) stock. On the other hand, the stock is +63.89% away from its low in the 90-day period. Specifically, they have bought $0.00 in company stock and sold $7,125,530.00 in company stock. Here is what Old West Investment Management said: Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. 45.30 +0.12 (0.27%)After hours: 4:32PM EST, Subscribe to Premium to view Fair Value for FLGT, featured highlights include: Winnebago, General Motors, 360 DigiTech, Fulgent Genetics and Ally Financial. Fulgent Genetics has received a consensus rating of Hold. 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. See what's happening in the market right now with MarketBeat's real-time news feed. 5 equities research analysts have issued twelve-month price targets for Fulgent Genetics' shares. Learn about financial terms, types of investments, trading strategies and more. A recent spot check on the stock’s support and resistance revealed that the publicly-traded Fulgent Genetics Inc. (NASDAQ: FLGT) shares are trading at a price close to -12.67% lower than its 90-day high. The company reported $2.08 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.39 by $1.69. Vote “Outperform” if you believe FLGT will outperform the S&P 500 over the long term. © American Consumer News, LLC dba MarketBeat® 2010-2020. Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutio... Zacks Investment Research - 2 weeks ago TEMPLE CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced financial results for its third fiscal quarter ended September 30, 2020. Includes articles, videos and real-time news from StockTwits. View real-time stock prices and stock quotes for a full financial overview. Stock analysis for Fulgent Genetics Inc (FLGT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Identify stocks that meet your criteria using seven unique stock screeners. FLGT | Complete Fulgent Genetics Inc. stock news by MarketWatch. Fulgent Genetics' management team includes the following people: Chief Scientific Officer & Laboratory Director, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You.